(Q37051591)

17 August 2017

0 references

1 reference

title

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials (English)

1 reference

Early Breast Cancer Trialists' Collaborative Group

17 August 2017

0 references

1 reference

1 reference

R Gray

9

0 references

1

object named as

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

1 reference

17 August 2017

M Clarke

2

1 reference

17 August 2017

A S Coates

3

1 reference

17 August 2017

S C Darby

4

1 reference

17 August 2017

C Davies

5

1 reference

17 August 2017

R D Gelber

6

1 reference

17 August 2017

J Godwin

7

1 reference

17 August 2017

A Goldhirsch

8

1 reference

17 August 2017

R Peto

10

1 reference

17 August 2017

K I Pritchard

11

1 reference

17 August 2017

W C Wood

12

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

371

1 reference

17 August 2017

9606

1 reference

17 August 2017

29-40

1 reference

describes a project that uses

17 August 2017

meta-analysis

0 references

cites work

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Estrogen receptor status and response to chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

Subsets within the chemotherapy overview. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960069-0

7 January 2021

10.1016/S0140-6736(08)60069-0

Identifiers

DOI

1 reference

17 August 2017

1 reference